Oral delivery of spray dried PLGA/amifostine nanoparticles

Journal of Pharmacy and Pharmacology

Volumn 56, Issue 9, 2004, Pages 1119-1125

  Pamujula, Sarala ^a   Graves, Richard A ^a   Freeman, Thomas ^a   Srinivasan, Venkataraman ^b   Bostanian, Levon A ^a   Kishore, Vimal ^a   Mandal, Tarun K ^a  

^a XAVIER UNIVERSITY OF LOUISIANA   (United States)

^b ARMED FORCES RADIOBIOLOGY RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (3 AMINOPROPYLAMINO)ETHANETHIOL; ALKALINE PHOSPHATASE; AMIFOSTINE; NANOPARTICLE; POLYGLACTIN; WATER OIL CREAM;

AIRFLOW; ANIMAL TISSUE; ARTICLE; BONE MARROW; CANCER CHEMOTHERAPY; CELL ENCAPSULATION; CONFIDENCE INTERVAL; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG METABOLISM; DRUG SELECTIVITY; DRUG TISSUE LEVEL; FEASIBILITY STUDY; JEJUNUM; KIDNEY; MOUSE; NONHUMAN; PARTICLE SIZE; SPRAY DRYING; TISSUE DISTRIBUTION;

ADMINISTRATION, ORAL; AMIFOSTINE; ANIMALS; DRUG DELIVERY SYSTEMS; LACTIC ACID; MALE; MICE; NANOSTRUCTURES; POLYGLYCOLIC ACID; POLYMERS; TISSUE DISTRIBUTION;

EID: 4444278416     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357044210     Document Type: Article

References (33)

1. Alpar, H. O., Field, W. N., Hyde, R., Lewis, D. A. (1989) The transport of microspheres from the gastro-intestinal tract to inflammatory air pouches in the rat. J. Pharm. Pharmacol. 41: 194-196
2. Anne, P. R., Curran, W. J. (2002) A phase II trial of subcutaneous amifostine and radiation therapy in patients with head and neck cancer. Semin. Radiat. Oncol. 12: 18-19
3. Bockmann, J., Lahl, H., Eckert, T., Unterhalt, B. (2000) Blood titanium levels before and after oral administration of titanium dioxide. Pharmazie 55: 140-143
4. Bonner, H. S., Shaw, L. M. (2002) New dosing regimens for amifostine: a pilot study to compare the relative bioavailability of oral and subcutaneous administration with intravenous infusion. J. Clin. Pharmacol. 42: 166-174
5. Cassatt, D. R., Fazenbaker, C. A., Bachy, C. M., Hanson. M. S. (2002) Preclinical modeling of improved amifostine (ethyol) use in radiation therapy. Sem. Rad. Oncol. 12: 97-102
6. De Jaeghere, F., Allemann, E., Kubel, F., Galli, B., Cozens, R., Doelker, E., Gurny, R. (2000) Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional state. J. Control. Release 68: 291-298
7. Desai, M. P., Labhasetwar, V., Amidon, G. L., Levy, R. J. (1996) Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm. Res. 13: 1838-1845
8. Ebel, J. P. (1990) A method for quantifying particle absorption from the small intestine of the mouse. Pharm. Res. 7: 848-851
9. Eldridge, J. H., Hammond, C. J., Meulbroek, J. A., Staas, J. K., Gilley, R. M., Rice, T. R. (1990) Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered. biodegradable microspheres target the Peyer's patches. J. Control. Release 11: 205-214
10. El-Shabouri, M. H. (2002) Positively charged nanoparticles for improving the oral bioavailability of cyclosporine-A. Int. J. Pharm. 249: 101-108
11. Fatome, M., Courteille, F., Laval, J. D., Roman, V. (1987) Radioprotective activity of ethylcellulose microspheres containing WR 2721, after oral administration. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 52: 21-29
12. Feng, S. S., Huang, G. F. (2001) Effects of phospholipids as emulsifiers on controlled release of paclitaxel from nanospheres of biodegradable polymers. J. Control. Release 71: 53-69
13. Florence, A. T. (1997) The oral absorption of micro- and nano-particulates: neither exceptional nor unusual. Pharm. Res. 14: 259-266
14. Florence, A. T., Jani, P. U. (1993) Particulate delivery: the challenge of the oral route. In: Rolland, A. (ed.) Pharmaceutical particulate carriers: therapeutic applications. Marcel Dekker, New York, p. 82
15. Godette, K. D. (2001) Clarification on the potential of subcutaneous ethyol as a radioprotective agent. J. Clin. Oncol. 19: 1582-1585
16. Guterres, S. S., Fessi, H., Barratt, G., Puisieux, F., Devissaquet, J. (1995) Poly(D,L-Lactide) nanocapsules containing nonsteroidal anti-inflammatory drugs: gastrointestinal tolerance following intravenous and oral administration. Pharm. Res. 12: 1545-1547
17. Hussain, N., Jaitley, V., Florence, A. T. (2001) Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv. Drug Dev. Rev. 50: 107-142
18. Jani, P. U., Halbert, G. W., Langridge, J., Forence, A. T. (1989) The uptake & translocation of latex nanospheres and microspheres after oral administration to rats. J. Pharm. Pharmacol. 41: 809-812
19. Jani, P., Halbert, G. W., Landridge, J., Florence, A. T. (1990) Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J. Pharm. Pharmacol. 42: 821-826
20. Jani, P. U., Florence, A. T., McCarthy, D. E. (1992) Further histological evidence of the gastrointestinal absorption of polystyrene nanospheres in the rat. Int. J. Pharm. 84: 245-252
21. Jenkins, P. G., Howard, K. A., Blackhall, N. W., Thomas, N. W., Davis, S. S., O'Hagan, D. T. (1994) Microparticle absorption from the rat intestine. J. Control. Release 29: 339-350
22. Koukourakis, M. L, Romanidis, K., Froudarakis, M., Kyrgias, G., Koukourakis, G. V., Retalis, G., Bahlitzanakis, N. (2002) Concurrent administration of docetaxel and stealth liposomal doxorubicin with radiotherapy in non-small cell lung cancer: excellent tolerance using subcutaneous amifostine for cytoprotection. Br. J. Cancer 87: 385-392
23. Lamperti, A., Ziskin, M. C., Bergey, E., Gorlowski, J., Sodicoff, M. (1990) Transdermal absorption of radioprotectors in the rat using permeation-enhancing vehicles. Radiat. Res. 124: 194-200
24. LeFevre, M. E., Olivo, R., Vanderhoff, J. W., Joel, D. D. (1978) Accumulation of latex in Peyer's patches and its subsequent appearance in villi and mesenteric lymph nodes. Proc. Soc. Exp. Biol. Med. 159: 298-302
25. LeFevre, M. E., Hancock, D. C., Joel, D. D. (1980) Intestinal barrier to large particulates in mice. J. Toxicol. Environ. Health 6: 691-704
26. Mu, L., Feng, S. S. (2001) Fabrication, characterization and in vitro release of paclitaxel loaded poly (lactic-co-glycolic acid) (PLGA) nanospheres prepared by the spray dry technique with phospholipids/cholesterol as additives. J. Control. Release 76: 239-254
27. Pamujula, S., Graves, R., Kishore, V., Mandal, T. K. (2004) Preparation and in vitro characterization of amifostine biodegradable microcapsules. Eur. J. Pharm. Biopharm. 57: 213-218
28. Payne, J. M., Sansom, B. F., Garner, R. J., Thomson, A. R., Miles, B. J. (1960) Uptake of small resin particles (1-5 microns diameter) by the alimentary canal of the calf. Nature 188: 586
29. Powel, J. J., Harvey, R. R., Ashwood, P., Wolstencroft, R., Gershwin, M. E., Thompson, R. P. (2000) Immune potentiation of ultrafine dietary particles in normal subjects and patients with inflammatory bowel disease. J. Autoimmun. 14: 99-105
30. Sanders, E., Ashworth, C. T. (1961) A study of particulate intestinal absorption and hepatocellular uptake: use of polystyrene latex particles. Exp. Cell. Res. 22: 137
31. Schuchter, L. M., Hensley, M. L, Meropol, N. J., Winer. E. P. (2002) Update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology. J. Clin. Oncol. 20: 2895-2903
32. Srinivasan, V., Pendergrass, J. A., Kumar, K. S., Landauer, M. R., Seed, T. M. (2002) Radioprotection, pharmacokinetic and behavioural studies in mouse implanted with biodegradable drug (amifostine) pellets. Int. J. Radiat. Biol. 78: 535-543
33. Wang, F. J. Wang, C. H. (2003) Etanidazole-loaded microspheres fabricated by spray-drying different poly(lactide/glycolide) polymers: effects on microspheres properties. J. Biomater. Sci. Polymer Edn. 14: 157-183